The bladder cancer-derived cell line RT112 expresses high levels of a FGFR3-TACC3 fusion protein [39] and is highly dependent on FGFR3 for its malignant phenotype [7, 40]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.